FIBRINOGEN - ANVISA Registration 80003610313

Access comprehensive regulatory information for FIBRINOGEN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80003610313 and manufactured by INSTRUMENTATION LABORATORY COMPANY. The registration is held by WERFEN MEDICAL LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including BIOSYSTEMS S.A., ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80003610313
Registration Details
ANVISA Registration Number: 80003610313
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Hemosil Controle Baixo de Fibrinogênio
Risk Class II

Registration Details

80003610313

25351343369201224

02004662000165

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Dec 24, 2012

VIGENTE

09/18/2025 19:00:01